Richard K. Prins - May 11, 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
May 11, 2021
Transactions value $
-$39,072
Form type
4
Date filed
5/13/2021, 06:42 PM
Next filing
May 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $260K +15.8K +40.42% $16.43 55K May 11, 2021 Direct
transaction AMPH Common Stock Sale -$299K -15.8K -28.78% $18.90 39.2K May 11, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -15.8K -61.28% $0.00 10K May 11, 2021 Common Stock 15.8K $16.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.70 to $19.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 Shares subject to the option are fully vested and immediately exercisable.